CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Lyne Laboratories

Lyne Laboratories is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Reliable Biopharmaceutical

cladribine, fluphenazine decanoate, pentamidine isethionate, fludarabine phosphate, phentolamine, chloramphenicol, api, us api manufacturer, us api supplier, best gmp manufacturer, most reliable source of api

D. Anderson and Company

D. Anderson and Company is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phagetech

Phagetech is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmacy Examining Board of Canada

Pharmacy Examining Board of Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.